Tuesday, October 22, 2019 12:35:16 PM
Recent BNGO News
- Bionano and Diagens Sign Partnership to Commercialize the First Ever Clinical Cytogenetic Analysis that Combines OGM and Artificial Intelligence • GlobeNewswire Inc. • 04/17/2024 12:00:00 PM
- Bionano Announces Publication Showing that OGM Detects Over 1250 Structural Variants, including 56 Gene Fusions, in Pediatric Leukemia that were Missed by Whole Genome Sequencing • GlobeNewswire Inc. • 04/11/2024 12:00:00 PM
- Bionano Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules • GlobeNewswire Inc. • 04/04/2024 05:44:35 PM
- Bionano Announces Publication Showing that OGM Identifies Genetic Aberrations in Sarcoma Samples that May Lead to Improved Diagnosis but were Missed by Classical Cytogenetics • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Bionano Announces 9 Poster Presentations and Introduces New High Throughput Stratys™ System at the American Association for Cancer Research Annual Meeting • GlobeNewswire Inc. • 04/02/2024 12:00:00 PM
- Bionano Announces Publication of a Breast Cancer Study Showing that the Number of SVs Detected with OGM May Be Related to Prognosis, Tumor Progression and Chemotherapy Resistance • GlobeNewswire Inc. • 03/19/2024 12:00:00 PM
- Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) Annual Meeting Including Live Product Showcase Featuring the Company’s New Stratys™ System • GlobeNewswire Inc. • 03/07/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:48:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:47:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:46:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:44:40 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/05/2024 10:26:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 09:23:48 PM
- Bionano Reports Fourth Quarter and Full-Year 2023 Results and Provides Revenue Outlook for 2024 • GlobeNewswire Inc. • 03/05/2024 09:01:00 PM
- Bionano to Present at TD Cowen’s 44th Annual Health Care Conference • GlobeNewswire Inc. • 02/29/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 01:16:10 PM
- Bionano to Report Fourth Quarter and Year End 2023 Financial Results and Host a Conference Call and Webcast on March 5, 2024 • GlobeNewswire Inc. • 02/28/2024 01:01:00 PM
- Bionano Announces Amendment to Debt Financing Arrangement to Extend Cash Runway • GlobeNewswire Inc. • 02/28/2024 01:00:00 PM
- American College of Medical Genetics and Genomics Includes OGM in Latest Edition of Technical Laboratory Standards for Solid Tumor Analysis • GlobeNewswire Inc. • 02/22/2024 01:00:00 PM
- Bionano to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science & Diagnostic Tools Conference • GlobeNewswire Inc. • 01/31/2024 01:00:00 PM
- Bionano’s Symposium 2024 Featured Presentations from its Global User Community Highlighting OGM as a Powerful Alternative to Classical Cytogenetics and Strong Complement to NGS • GlobeNewswire Inc. • 01/30/2024 01:00:00 PM
- Bionano Announces Publication of Interim Readout from Second Phase of Clinical Trial Analyzing Optical Genome Mapping as Standard of Care (SOC) for Prenatal Testing • GlobeNewswire Inc. • 01/24/2024 01:00:00 PM
- Bionano Announces Full Commercial Release of the Stratys™ System for High Throughput Optical Genome Mapping • GlobeNewswire Inc. • 01/23/2024 01:00:00 PM
- Bionano Announces the Final Speaker Lineup for 2024 Symposium with 33 OGM Presentations and Live Panel Discussions Across a Wide Range of Research Applications • GlobeNewswire Inc. • 01/19/2024 01:00:00 PM
- Bionano Announces Peer-Reviewed Publication from its Clinical Study Designed to Support OGM as Part of Standard of Care (SOC) in Genetic Disease Testing • GlobeNewswire Inc. • 01/11/2024 09:01:00 PM
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM